SSB8

0.545

-0.015 (-2.7%)

TAKE-OVERS & MERGERS (PARAGRAPH/RULE 9.19 (47A))

SOUTHERN SCORE BUILDERS BERHAD

Type Announcement
Subject TAKE-OVERS & MERGERS (PARAGRAPH/RULE 9.19 (47A))
Description
UNCONDITIONAL MANDATORY TAKE-OVER OFFER BY SOUTHERN SCORE BUILDERS BERHAD ("SSBB" OR "OFFEROR") THROUGH KENANGA INVESTMENT BANK BERHAD ("KENANGA IB") TO ACQUIRE ALL THE REMAINING ORDINARY SHARES IN NOVA PHARMA SOLUTIONS BERHAD NOT ALREADY HELD BY THE OFFEROR AND PERSONS ACTING IN CONCERT WITH IT ("OFFER SHARES") FOR A CASH CONSIDERATION OF RM0.37 PER OFFER SHARE ("OFFER")

Reference is made to SSBB’s announcements dated 22 December 2025, 12 January 2026, 23 January 2026, 29 January 2026 and 3 February 2026 in relation to the Offer (“Announcements”). Unless otherwise stated, all abbreviations and definitions used herein shall have the same meaning as those used in SSBB’s Announcements.

 
On behalf of the Offeror, Kenanga IB wishes to announce that the Offer has closed at 5:00 p.m. (Malaysian time) on Friday, 27 February 2026 being the Extended Closing Date.

 

In accordance with paragraph 13.01 of the Rules, the level of acceptances of the Offer as at 5:00 p.m. (Malaysian time) on Friday, 27 February 2026 is set out in the attached press release.

 

As announced by the Company on 3 February 2026, the Offeror had received Valid Acceptance of not less than nine-tenths in the nominal value of the Offer Shares (excluding NPS Shares already held by the Offeror and its PACs as at the date of the Offer) as at 5:00 p.m. (Malaysian time) on Tuesday, 3 February 2026.

 

Accordingly, the Offeror will issue a compulsory acquisition notice in the form or manner specified by the SC under subsection 222(1) of the CMSA to all Dissenting Shareholders.

 

This announcement is dated 27 February 2026.




Please refer attachment below.

Attachments

Press Notice (27.2.2026).pdf
286.3 kB



Announcement Info

Company Name SOUTHERN SCORE BUILDERS BERHAD
Stock Name SSB8
Date Announced 27 Feb 2026
Category General Announcement for PLC
Reference Number GA1-27022026-00064